Khaled Musallam/LinkedIn
Sep 26, 2026, 14:54
Khaled Musallam: TIF Guidelines Advance Emergency Care for Blood-Disorders
Khaled Musallam, Chief of Cell and Gene Therapy and Hematology in Burjeel Cancer Institute, shared a post on LinkedIn:
“Privileged to serve as Managing Editor alongside an exceptional team of Editors for the new edition of the Thalassaemia International Federation (TIF) Guidelines for the Emergency Management of Thalassaemia and Sickle Cell Disease.
A practical resource to support timely and effective emergency care for people living with haemoglobin disorders worldwide.”
Stay updated with Hemostasis Today.
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis
-
Sep 26, 2026, 15:27Berkan Kurt: The Role of Biomarkers in Cardiovascular Prevention
-
Sep 26, 2026, 15:21Consuela A. Albright: Five Concrete Ways Steps to Advocate for Sickle Cell Disease